(a) This part does not create a private cause of action against a manufacturer of an individualized investigational treatment or against any other person or entity involved in the care of an eligible patient using the individualized investigational treatment for any harm done to the eligible patient resulting from the individualized investigational treatment, if the manufacturer or other person or entity is complying in good faith with the terms of this part and has exercised reasonable care.
(b) This part does not affect any mandatory healthcare coverage for participation in clinical trials under § 56-7-2365.